Alzamend Neuro (ALZN) Stock Chart & Stock Price History $1.11 -0.14 (-11.20%) (As of 12/20/2024 05:51 PM ET) Add Compare Share Share Chart Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends Alzamend Neuro Stock Price Performance 5 Day Performance-13.95%1 Month Performance-15.27%3 Month Performance-34.32%6 Month Performance-73.57%Year-To-Date Performance-87.53%1 Year Performance-87.69% Receive ALZN Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Alzamend Neuro and its competitors with MarketBeat's FREE daily newsletter. Email Address Why Buffett, Griffin and 100 members of Congress are Piling into this One Investment (Ad)This isn't just another investment. It might be the last retirement stock you'll ever need. But this window of opportunity is closing fast.Click here for the ticker >>> ALZN Stock Chart for Sunday, December, 22, 2024 ALZN Chart by TradingView Alzamend Neuro Stock Price History Daily Weekly Monthly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year Time Frame * Start Date * End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization12/20/2024$1.25$1.11-11.20%$1.22$1.11786,110 shs$4.32 million12/19/2024$1.23$1.25+1.63%$1.28$1.18149,829 shs$4.86 million12/18/2024$1.29$1.23-4.65%$1.33$1.22148,562 shs$4.79 million12/17/2024$1.22$1.29+5.74%$1.30$1.21153,134 shs$5.02 million12/16/2024$1.19$1.22+2.52%$1.34$1.16255,092 shs$4.75 million12/13/2024$1.19$1.19$1.23$1.1884,524 shs$4.63 million Get the Latest News and Ratings for ALZN and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Alzamend Neuro and its competitors with MarketBeat's FREE daily newsletter. 12/12/2024$1.20$1.19-0.83%$1.20$1.1763,934 shs$4.63 million12/11/2024$1.23$1.20-2.44%$1.24$1.1833,893 shs$4.67 million12/10/2024$1.25$1.23-1.60%$1.27$1.17103,027 shs$4.79 million12/09/2024$1.14$1.25+9.65%$1.27$1.06333,789 shs$4.86 million12/06/2024$1.15$1.14-0.87%$1.16$1.12127,214 shs$4.44 million12/05/2024$1.19$1.15-3.36%$1.18$1.13110,860 shs$4.47 million12/04/2024$1.25$1.19-4.80%$1.26$1.18201,688 shs$4.63 million12/03/2024$1.25$1.25$1.30$1.2292,860 shs$4.86 million12/02/2024$1.30$1.25-3.85%$1.32$1.24221,308 shs$4.86 million11/29/2024$1.27$1.30+2.77%$1.30$1.2755,817 shs$5.06 million11/28/2024$1.27$1.27$1.30$1.26120,595 shs$4.92 million11/27/2024$1.29$1.27-1.56%$1.30$1.26119,586 shs$4.92 million11/26/2024$1.31$1.29-1.91%$1.35$1.27115,937 shs$5.00 million11/25/2024$1.31$1.31$1.36$1.29181,095 shs$5.10 million11/22/2024$1.30$1.31+0.77%$1.31$1.2796,613 shs$5.10 million11/21/2024$1.31$1.30-0.76%$1.32$1.27132,012 shs$5.06 million Related Companies Citius Pharmaceuticals Stock Chart Finch Therapeutics Group Stock Chart Cognition Therapeutics Stock Chart Cadrenal Therapeutics Stock Chart MIRA Pharmaceuticals Stock Chart Unity Biotechnology Stock Chart Carisma Therapeutics Stock Chart Pieris Pharmaceuticals Stock Chart Aprea Therapeutics Stock Chart Synlogic Stock Chart Receive ALZN Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Alzamend Neuro and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:ALZN) was last updated on 12/22/2024 by MarketBeat.com Staff From Our PartnersThis Crypto Is Set to Explode in DecemberIt's a groundbreaking opportunity that could be poised for extraordinary gains. The catalyst behind this su...Crypto 101 Media | SponsoredWARNING: “Buffett Indicator” flashing for first time in 50 yearsWarren Buffett has sold a staggering $97 billion worth of stocks this year... But why? Our research indi...Behind the Markets | SponsoredYour bank is lying to you.You might think you have your money in a high-yield savings account, but do you really? The national average A...MyBankTracker | SponsoredRare "crisis signal" triggers for third time in U.S. marketA rare pattern has just repeated for the third time in U.S. history. The last two times this happened, the...Stansberry Research | SponsoredCould This Tiny Device Help You Make an Extra $30k a Year?I believe it’s going to power Elon Musk’s next AI revolution… A revolution he believes will be worth more t...Brownstone Research | SponsoredVladimir Lenin was right…The Magnificent 7 could be in for a world of pain… And the insiders know it. It’s why Jeff Bezos just sold ...Porter & Company | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowAltcoin season moves fast, and those who hesitate are left behind. The window is closing.Crypto Swap Profits | SponsoredHOTTEST TRADER IN AMERICA 🔥🔥🔥Ready for a rocket ride this weekend? After alerting his readers to a tiny $2 stock called Bright Minds Bio...Timothy Sykes | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Alzamend Neuro, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Alzamend Neuro With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free ALZN Stock Alerts